Twist Bioscience Q2 revenue $48.1M (+54% YoY), orders $55.0M (+32% YoY)

Twist Bioscience Corp

2022-Q2 EPS reported -$2.06 revenue$90,145,000

Record revenue $48.1M, up 54% YoY from $31.2M.
Net loss $60.7M ($1.13/share) vs $37.9M ($0.78) prior year.
Orders $55.0M, up 32% YoY from $41.7M.
Four-year supply agreement with Ginkgo Bioworks, $58M minimum purchases over contract term.
Cash $604.4M; raised $269.8M net from public offering completed in the quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.